- Home
- Services
- Model Informed Drug Development (MIDD)
- Population Pharmacokinetics
- Physiologically based Pharmacokinetic modeling
- Drug-Drug Interactions (DDI) analysis
- Pharmacokinetics NCA
- CDISC compliance of PK Data
- Modeling & Simulation
- Guiding dose selection
- Filling for health agencies
- Target-Mediated Drug Disposition
- QT / QTc Analysis (TQT) for cardiac safety
- Integrated Phase 1 Solutions
- Resources
- About us
- News
- [Webinar]: AI in drug development
- FDA event: PBPK best practices
- Modeling & Simulation Strategies Must Be Integrated into Clinical Development
- Blaise Pasquiers presents the mAbs project at PhinC
- Fexinidazole awarded a spot in 2020 medicines list
- Read our latest article about IVIVC
- CDISC standards by Michaël Boily
- COVID-19 | Contingency and continuity plan
- Development of a new intra-articular module
- PhinC renews sponsorship to GMP annual symposium
- The success of our PBPK symposium 2019
- EMA gave a positive opinion about Fexinidazole
- Careers
- Contact our Experts!
- Legal notice
- Privacy policy
- Search
- Paramètres emploi
- Sitemap
- Déposer votre CV
- Services
